FC 113 – Consent: making patient information understandable (08:30 – 09:30)
Evaluate

FS 111 – Technical questions for endovascular fem-pop disease treatment (08:30 – 09:30)
Evaluate

FS 112 – Intrahepatic cholangiocarcinoma- what can you offer? (08:30 – 09:30)
Evaluate

FS 114 – Ablative treatments for benign conditions (08:30 – 09:30)
Evaluate

HDT-EMT 11.3 – Embolization: coils & plugs (08:30 – 10:00)
Evaluate

HDT-VAT 11.4 – Vertebral augmentation (08:30 – 10:00)
Evaluate

HDT-VT 11.2 – Venous thrombectomy / DVT-PE (08:30 – 10:00)
Evaluate

HGI 11.1 – Hands-on GI lab (08:30 – 10:00)
Evaluate

SIM 1.1 – Peripheral arterial disease (08:30 – 09:50)
Evaluate

ST 115 – Introducing IR (08:30 – 09:30)
Evaluate

SIM 1.2 – Peripheral arterial disease (09:50 – 11:10)
Evaluate

FS 122 – Colorectal cancer metastatic disease: burning issues (10:00 – 11:00)
Evaluate

FS 123 – Managing your life as an IR (10:00 – 11:00)
Evaluate

FS 124 – Biliary intervention (10:00 – 11:00)
Evaluate

FS 125 – MSK (10:00 – 11:00)
Evaluate

IRT 126 – Future technologies in IR (10:00 – 11:00)
Evaluate

MPJ 121 – Dealing with the diabetic foot (10:00 – 11:00)
Evaluate

SIM 1.3 – Peripheral arterial disease (11:10 – 12:30)
Evaluate

ST-HDT EMT 13.1 – Embolization: coils & plugs for students (11:15 – 12:15)
Evaluate

CBD 134 – Pelvic venous: how can one disease need so many treatment approaches? (11:30 – 12:30)
Evaluate

FC 133 – So you are an IR – but are you really a clinician? (11:30 – 12:30)
Evaluate

FC 135 – From thyroid to haemorrhoids (11:30 – 12:30)
Evaluate

MPJ 132 – MSK (11:30 – 12:30)
Evaluate

SP 131 – FIRST@CIRSE – First data release on vascular IR trials and studies (11:30 – 12:30)
Evaluate

WIR 136 – Women in IR (11:30 – 12:30)
Evaluate

HDT-EMT 14.3 – Embolization: coils & plugs (13:00 – 14:30)
Evaluate

HDT-VAT 14.4 – Vertebral augmentation (13:00 – 14:30)
Evaluate

HDT-VT 14.2 – Venous thrombectomy / DVT-PE (13:00 – 14:30)
Evaluate

HGI 14.1 – Hands-on GI lab for students (13:00 – 14:30)
Evaluate

MPI 141 – Meet the PI: cutting edge trials in IO (13:00 – 14:00)
Evaluate

SIM 1.4 – Peripheral arterial disease (14:00 – 15:20)
Evaluate

SIM 1.5 – Peripheral arterial disease (15:20 – 16:40)
Evaluate

ERT 161 – Proper preparation of the femoral-popliteal arterial segment (16:15 – 17:15)
Evaluate

ERT 162 – Colorectal cancer: liver metastatic disease (16:15 – 17:15)
Evaluate

ERT 163 – Trial updates on stroke treatments (16:15 – 17:15)
Evaluate

FS 164 – Post-thrombotic deep venous occlusions: current challenges, future promise (16:15 – 17:15)
Evaluate

HDT-CT 16.4 – CBCT and image-guided fusion (16:15 – 17:45)
Evaluate

HDT-EMT 16.3 – Embolization: particulate agents (16:15 – 17:45)
Evaluate

HDT-VV 16.2 – Varicose veins (16:15 – 17:45)
Evaluate

HGI 16.1 – Hands-on GI lab (16:15 – 17:45)
Evaluate

SP 166 – Outcomes of new devices in PAD (16:15 – 17:15)
Evaluate

SP 167 – Selective treatments for ocular and bone malignancies (16:15 – 17:15)
Evaluate

WS 165 – MSK embolization (16:15 – 17:15)
Evaluate

NA 168 – The 4th global IR summit: visibility of IR (16:30 – 18:30)
Evaluate

ST-SIM 1.6 – Peripheral arterial disease – Simulation training for students (17:00 – 18:00)
Evaluate

ERT 171 – Below the knee vessel prep: what really works? (17:30 – 18:30)
Evaluate

ETF 174 – Interdisciplinary collaboration: the future of IR (17:30 – 18:30)
Evaluate

FS 172 – Focal prostate cancer therapy (17:30 – 18:30)
Evaluate

FS 173 – Carotid artery stenting in acute stroke situations (17:30 – 18:30)
Evaluate

SP 175 – MSK embolization new frontiers (17:30 – 18:30)
Evaluate

SP 176 – Liver tumour board (17:30 – 18:30)
Evaluate

SP 177 – Dialysis & central venous intervention (17:30 – 18:30)
Evaluate

CS 211 – Controversies in the management of complications after paediatric liver transplantation (08:30 – 09:30)
Evaluate

FC 213 – Acute lower extremity DVT (08:30 – 09:30)
Evaluate

FC 214 – Embolization of intracranical aneurysm: learning from the experts (08:30 – 09:30)
Evaluate

FS 212 – Breast (08:30 – 09:30)
Evaluate

FS 215 – Pain management (08:30 – 09:30)
Evaluate

HDT-CT 21.4 – CBCT and image-guided fusion (08:30 – 10:00)
Evaluate

HDT-EMT 21.3 – Embolization: particulate agents (08:30 – 10:00)
Evaluate

HDT-VV 21.2 – Varicose veins (08:30 – 10:00)
Evaluate

HGI 21.1 – Hands-on GI lab (08:30 – 10:00)
Evaluate

SIM 2.1 – Prostatic artery embolization (08:30 – 09:50)
Evaluate

SIM 2.2 – Prostatic artery embolization (09:50 – 11:10)
Evaluate

CS 224 – Controversies in carotid intervention (10:00 – 11:00)
Evaluate

ERT 225 – Cryoneurolysis (10:00 – 11:00)
Evaluate

FC 223 – Portal hypertension in children (10:00 – 11:00)
Evaluate

FS 222 – Ablative therapies for HCC and liver mets (10:00 – 11:00)
Evaluate

IRT 227 – Innovation in IR (10:00 – 11:00)
Evaluate

MPJ 226 – Prostate artery embolization (10:00 – 11:00)
Evaluate

SED 22.5 – Safe sedation application during IR procedures – basic (10:00 – 11:30)
Evaluate

VL 221 – Advanced arterial video learning (10:00 – 11:00)
Evaluate

ST-HDT EMT 23.1 – Varicose veins for students (10:45 – 11:45)
Evaluate

SIM 2.3 – Prostatic artery embolization (11:10 – 12:30)
Evaluate

ST-HDT EMT 23.2 – Embolization: liquid agents for students (11:15 – 12:15)
Evaluate

CM 231 – CIRSE meets EAPCI: renal denervation (11:30 – 12:30)
Evaluate

HDT-CLP 24.2 – Central lines and ports (13:00 – 14:30)
Evaluate

HDT-EMT 24.3 – Embolization: liquid agents (13:00 – 14:30)
Evaluate

HDT-ST 24.4 – Stroke thrombectomy (13:00 – 14:30)
Evaluate

HGI 24.1 – Hands-on GI lab for students (13:00 – 14:30)
Evaluate

MPI 241 – Meet the PI: embolization and more (13:00 – 14:00)
Evaluate

SED 24.5 – Safe sedation application during IR procedures – basic (13:00 – 14:30)
Evaluate

SIM 2.4 – Prostatic artery embolization (14:00 – 15:20)
Evaluate

FIQ 251 – Film Interpretation Quiz (14:30 – 15:15)
Evaluate

HTS 252 – Pulmonary embolism (15:15 – 16:00)
Evaluate

SIM 2.5 – Prostatic artery embolization (15:20 – 16:40)
Evaluate

AI 263 – Amazing Interventions (16:15 – 17:15)
Evaluate

ERT 261 – Aorto-iliac occlusive disease (16:15 – 17:15)
Evaluate

FS 262 – Interventional immuno-oncology: bridging the gap between IR and cancer immunotherapy (16:15 – 17:15)
Evaluate

FS 264 – A new kid on the block: middle meningeal artery embolization for chronic subdural haematoma (16:15 – 17:15)
Evaluate

FS 265 – Life-saving IR in neonates and infants (16:15 – 17:15)
Evaluate

FS 269c – Liver cancer and quality assurance: integrating clinical excellence with safe practice (16:15 – 17:15)
Evaluate

HDT-CLP 26.1 – Central lines and ports (16:15 – 17:45)
Evaluate

HDT-EMT 26.2 – Embolization: liquid agents (16:15 – 17:45)
Evaluate

HDT-ST 26.3 – Stroke thrombectomy (16:15 – 17:45)
Evaluate

SED 26.4 – Safe sedation application during IR procedures – advanced (16:15 – 17:45)
Evaluate

SP 266 – Cutting edge therapies in renal and prostatic malignancy (16:15 – 17:15)
Evaluate

SP 267 – IR Management- let’s shift from passive to active! (16:15 – 17:15)
Evaluate

SP 268 – Are there any limits to MSK interventions? (16:15 – 17:15)
Evaluate

ST-SIM 2.6 – Prostatic artery embolization – Simulation training for students (17:00 – 18:00)
Evaluate

ETF 274 – Work-life balance in IR (17:30 – 18:30)
Evaluate

FC 272 – Biopsies and drainage in children (17:30 – 18:30)
Evaluate

FS 271 – Drug-coated balloon in the fem-pop segment: what is the evidence? (17:30 – 18:30)
Evaluate

FS 275 – Women’s health (17:30 – 18:30)
Evaluate

SP 276 – Advanced imaging guidance in IO (17:30 – 18:30)
Evaluate

SP 277 – Neuro and carotid interventions (17:30 – 18:30)
Evaluate

SP 278 – EVAR, FEVAR and beyond! (17:30 – 18:30)
Evaluate

WS 273 – Central venous access (17:30 – 18:30)
Evaluate

CS 313 – Controversies in IO (08:30 – 09:30)
Evaluate

FC 312 – Acute limb ischaemia (08:30 – 09:30)
Evaluate

FS 311 – Unsolved issues in standard EVAR (08:30 – 09:30)
Evaluate

FS 314 – Complex superior/inferior vena cava reconstruction (08:30 – 09:30)
Evaluate

FS 315 – Complications in PIR: how I manage them (08:30 – 09:30)
Evaluate

HDT-AA 31.2 – Arterial atherectomy (08:30 – 10:00)
Evaluate

HDT-TA 31.3 – Tumour ablation: heat-based (MWA, RFA) (08:30 – 10:00)
Evaluate

HDT-VS 31.1 – Venous stenting practice (08:30 – 10:00)
Evaluate

SIM 3.1 – Acute and chronic mesenteric ischaemia (08:30 – 09:50)
Evaluate

SIM 3.2 – Acute and chronic mesenteric ischaemia (09:50 – 11:10)
Evaluate

CBD 325 – IR in teenagers: does the treatment approach differ between adult and paediatric patients? (10:00 – 11:00)
Evaluate

CS 322 – Supraaortic interventions (10:00 – 11:00)
Evaluate

FS 323 – HCC: what’s new in 2025 (10:00 – 11:00)
Evaluate

IRT 326 – Therapies and treatments (10:00 – 11:00)
Evaluate

SED 32.1 – Safe sedation application during IR procedures – basic (10:00 – 11:30)
Evaluate

VL 321 – Complex aorto-iliac aneurysm repair (10:00 – 11:00)
Evaluate

VL 324 – Masters of the venous universe (10:00 – 11:00)
Evaluate

SIM 3.3 – Acute and chronic mesenteric ischaemia (11:10 – 12:30)
Evaluate

IRT 332 – Next generation IVUS Case Competition (11:15 – 12:45)
Evaluate

ST-HDT TA 33.1 – Tumour ablation: heat-based for students (11:15 – 12:15)
Evaluate

CM 331 – CIRSE meets SIOPE: the future of paediatric oncology (11:30 – 12:30)
Evaluate

HDT-AA 34.3 – Arterial atherectomy (13:00 – 14:30)
Evaluate

HDT-TA 34.4 – Tumour ablation: heat-based (MWA, RFA) (13:00 – 14:30)
Evaluate

HDT-VS 34.2 – Venous stenting practice (13:00 – 14:30)
Evaluate

PC 34.1 – IDEAS practical course: Standard EVAR: indication and adjuncts (13:00 – 14:30)
Evaluate

SED 34.5 – Safe sedation application during IR procedures – advanced (13:00 – 14:30)
Evaluate

SIM 3.4 – Acute and chronic mesenteric ischaemia (14:00 – 15:20)
Evaluate

ERT 351 – Acute type B dissection (14:30 – 15:30)
Evaluate

HL 352 – Andreas Gruentzig Lecture: Breaking barriers in breast cancer: cryoablation as the ultimate expression of IO’s de-escalation philosophy (14:30 – 15:00)
Evaluate

ST 356 – Students on stage (14:30 – 15:30)
Evaluate

HTS 353 – Systemic therapies and interventional therapies for HCC: evidence and future prospects (15:00 – 16:00)
Evaluate

SIM 3.5 – Acute and chronic mesenteric ischaemia (15:20 – 16:40)
Evaluate

ERT 361 – Thoraco-abdominal endovascular repair (16:15 – 17:15)
Evaluate

ERT 363 – CRC liver thermal ablation trials: is this really a paradigm shift? (16:15 – 17:15)
Evaluate

FC 362 – Arterio-venous malformations in children- how they can be managed by IR (16:15 – 17:15)
Evaluate

FS 364 – Let’s take a new look at female pelvic venous disease (16:15 – 17:15)
Evaluate

FS 365 – EBIR preparation for candidates (16:15 – 17:15)
Evaluate

HDT-CD 36.3 – A closer look at closure devices (16:15 – 17:45)
Evaluate

HDT-PAF 36.2 – Percutaneous arteriovenous fistulas: the way forward (16:15 – 17:45)
Evaluate

HDT-TA 36.4 – Tumour ablation: non-thermal (IRE, electrochemotherapy) (16:15 – 17:45)
Evaluate

PC 36.1 – IDEAS practical course: TEVAR with single branch (16:15 – 17:45)
Evaluate

SED 36.5 – Safe sedation application during IR procedures – advanced (Propofol) (16:15 – 17:45)
Evaluate

SP 366 – Visceral artery delights – the devil is is in the detail! (16:15 – 17:15)
Evaluate

SP 367 – Prostate artery embolization: a modern IR pillar (16:15 – 17:15)
Evaluate

SP 368 – Catheter treatments in pulmonary embolism and deep vein thrombosis (16:15 – 17:15)
Evaluate

ST-SIM 3.6 – Acute and chronic mesenteric ischaemia – Simulation training for students (17:00 – 18:00)
Evaluate

CBD 371 – Amazing bailouts in complex EVAR (17:30 – 18:30)
Evaluate

ETF 373 – Women trainees in IR (17:30 – 18:30)
Evaluate

FS 375 – Dealing with complications (17:30 – 18:30)
Evaluate

MPJ 372 – Mesenteric ischaemia (17:30 – 18:30)
Evaluate

SP 376 – Focused therapies for challenging tumours (17:30 – 18:30)
Evaluate

SP 377 – Novel upper gastro-intestinal and hepato-biliary interventions (17:30 – 18:30)
Evaluate

SP 378 – Venous miscellany (17:30 – 18:30)
Evaluate

WS 374 – Adrenal vein sampling (17:30 – 18:30)
Evaluate

FC 412 – Accurate arterial access (08:30 – 09:30)
Evaluate

FC 414 – Dialysis dilemmas (08:30 – 09:30)
Evaluate

FS 411 – Ongoing issues in the aortic arch (08:30 – 09:30)
Evaluate

FS 413 – Hot topics in lung ablation (08:30 – 09:30)
Evaluate

FS 415 – Percutaneous thyroid interventions (08:30 – 09:30)
Evaluate

HDT-CD 41.1 – A closer look at closure devices (08:30 – 10:00)
Evaluate

HDT-NB 41.4 – Nerve blocks and neurolysis (08:30 – 10:00)
Evaluate

HDT-PAF 41.3 – Percutaneous arteriovenous fistulas: the way forward (08:30 – 10:00)
Evaluate

HDT-TA 41.2 – Tumour ablation: cold-based (08:30 – 10:00)
Evaluate

SIM 4.1 – Uterine artery embolization (08:30 – 09:50)
Evaluate

SIM 4.2 – Uterine artery embolization (09:50 – 11:10)
Evaluate

CBD 421 – Addressing aorto-iliac ruptures (10:00 – 11:00)
Evaluate

CBD 423 – Lung ablation: real life hard-core complex cases (10:00 – 11:00)
Evaluate

ERT 425 – Interventional radiology and diagnostic radiology: is it time for a velvet divorce? (10:00 – 11:00)
Evaluate

FS 422 – Bioresorbable scaffolds in tibial arteries (10:00 – 11:00)
Evaluate

IRT 426 – Complications during training: a case-based session (10:00 – 11:00)
Evaluate

MPJ 424 – Pulmonary embolism: let’s get this right first time! (10:00 – 11:00)
Evaluate

HDT-AT 42.1 – Arterial thrombectomy (11:00 – 12:30)
Evaluate

SIM 4.3 – Uterine artery embolization (11:10 – 12:30)
Evaluate

ST-HDT TA 43.1 – Tumour ablation: cold-based for students (11:15 – 12:15)
Evaluate

CBD 434 – Pulmonary embolism: interventional strategy and technical aspects (11:30 – 12:30)
Evaluate

ERT 435 – Invention for innovation (11:30 – 12:30)
Evaluate

FS 431 – Endoleaks after EVAR (11:30 – 12:30)
Evaluate

FS 432 – Erectile dysfunction: diagnostic work-up and endovascular treatment (11:30 – 12:30)
Evaluate

MPJ 433 – Neuroendocrine imaging and intervention (11:30 – 12:30)
Evaluate

MPJ 436 – IRs need to be involved in trauma treatment (11:30 – 12:30)
Evaluate

HDT-NB 44.4 – Nerve blocks and neurolysis (13:00 – 14:30)
Evaluate

HDT-TA 44.2 – Tumour ablation: cold-based (13:00 – 14:30)
Evaluate

PC 44.3 – IDEAS practical course: FEVAR and BEVAR tips and tricks (13:00 – 14:30)
Evaluate

SIM 4.4 – Uterine artery embolization (14:00 – 15:20)
Evaluate

HL 451 – Josef Roesch Lecture: The unlikely journey into MSK embolization and the forces that drove it (14:30 – 15:00)
Evaluate

HTS 452 – Breaking the limits in the aortic field (15:00 – 16:00)
Evaluate

HTS 453 – Practice building in interventional radiology (15:00 – 16:00)
Evaluate

SIM 4.5 – Uterine artery embolization (15:20 – 16:40)
Evaluate

ERT 461 – Do the results justify the use of modified EVAR? (16:15 – 17:15)
Evaluate

ERT 463 – The rise of the machines (16:15 – 17:15)
Evaluate

FS 462 – Benign liver lesions (16:15 – 17:15)
Evaluate

FS 464 – Acute DVT (16:15 – 17:15)
Evaluate

FS 465 – Maximise the value of IR time (16:15 – 17:15)
Evaluate

HDT-AT 46.1 – Arterial thrombectomy (16:15 – 17:45)
Evaluate

NA 467 – Advancing IR together: current status of IR in Egypt (16:15 – 17:15)
Evaluate

SP 466 – FIRST@CIRSE – First data release on various IR trials and studies (16:15 – 17:15)
Evaluate

ST-SIM 4.6 – Uterine artery embolization – Simulation training for students (17:00 – 18:00)
Evaluate

CBD 471 – My nightmare aortic endovascular case (17:30 – 18:30)
Evaluate

ETF 472 – Developing IR (17:30 – 18:30)
Evaluate

MPJ 474 – Acute upper extremity DVT (17:30 – 18:30)
Evaluate

SP 475 – What’s hot in peripheral arterial intervention? (17:30 – 18:30)
Evaluate

SP 476 – Precision and technical expertise in UFE (17:30 – 18:30)
Evaluate

SP 477 – Portal venous intervention (17:30 – 18:30)
Evaluate

WS 473 – Radioembolization (17:30 – 18:30)
Evaluate

FC 513 – Drainage (08:30 – 09:30)
Evaluate

FS 511 – Renal cell carcinoma (08:30 – 09:30)
Evaluate

MPJ 512 – Portal hypertension in adults (08:30 – 09:30)
Evaluate

CBD 521 – Beyond T1a renal cell carcinoma (10:00 – 11:00)
Evaluate

FS 523 – Burning issues in urology (10:00 – 11:00)
Evaluate

WS 522 – Endo AVF (10:00 – 11:00)
Evaluate

MM 531 – Morbidity and Mortality Conference (11:30 – 12:30)
Evaluate